AB154

· Arcus Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AB154, covering 2025-02-04 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: AB154 Combined With AB122 for Recurrent Glioblastoma [EARLY_Phase 1]